Vascular endothelial growth factor attenuates status epilepticus-induced behavioral impairments in rats.
Vascular endothelial growth factor (VEGF) is a vascular growth factor more recently recognized as a neurotrophic factor (for review, see Storkebaum E, Lambrechts D, Carmeliet P. BioEssays 2004;26:943-54). We previously reported that endogenous VEGF protein is dramatically upregulated after pilocarpine-induced status epilepticus in the rat, and that intra-hippocampal infusions of recombinant human VEGF significantly protected against the loss of hippocampal CA1 neurons in this model (Nicoletti JN, Shah SK, McCloskey DP, et al. Neuroscience 2008;151:232-41). We hypothesized that we would see a preservation of cognitive and emotional functioning with VEGF treatment accompanying the neuroprotection previously observed in this paradigm. Using the Morris water maze to evaluate learning and memory, and the light-dark task to assess anxiety, we found a selective profile of preservation. Specifically, VEGF completely preserved normal anxiety functioning and partially but significantly protected learning and memory after status epilepticus. To determine whether the ability of VEGF to attenuate behavioral deficits was accompanied by sustained preservation of hippocampal neurons, we stereologically estimated CA1 pyramidal neuron densities 4 weeks after status epilepticus. At this time point, we found no significant difference in neuronal densities between VEGF- and control-treated status epilepticus animals, suggesting that VEGF could have protected hippocampal functioning independent of its neuroprotective effect.
Nicoletti
Jamee N
JN
Neuropsychology Doctoral Subprogram, Graduate Center, City University of New York, New York, NY 11367, USA.
Lenzer
Janice
J
Salerni
Elisa A
EA
Shah
Sachin K
SK
Elkady
Ahmed
A
Khalid
Sidra
S
Quinteros
Dean
D
Rotella
Francis
F
Betancourth
David
D
Croll
Susan D
SD
D000221:Adaptation, Ocular / Q000187:drug effects; D000704:Analysis of Variance; D000818:Animals; D001526:Behavioral Symptoms / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D004195:Disease Models, Animal; D006624:Hippocampus / Q000473:pathology; D006801:Humans; D008124:Locomotion / Q000187:drug effects; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D010862:Pilocarpine; D017966:Pyramidal Cells / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000627:therapeutic use; D013226:Status Epilepticus / Q000139:chemically induced / Q000150:complications*; D042461:Vascular Endothelial Growth Factor A / Q000627:therapeutic use*
D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D010862:Pilocarpine
J Neurosci. 2003 Dec 17;23(37):11505-15
14684854
J Cereb Blood Flow Metab. 2005 Dec;25(12):1557-72
15889042
Epilepsy Behav. 2005 Dec;7 Suppl 3:S3-11
16278099
Epilepsy Res. 1997 Jan;26(2):363-71
9095398
Exp Neurol. 2007 Oct;207(2):329-49
17714705
Exp Neurol. 2009 Sep;219(1):284-97
19500573
Seizure. 2002 Jun;11(4):224-30
12027568
Learn Mem. 2006 Jan-Feb;13(1):18-26
16418436
Prog Brain Res. 2002;135:67-83
12143371
Exp Neurol. 1998 Feb;149(2):398-410
9500963
Bioessays. 2004 Sep;26(9):943-54
15351965
Anat Rec. 1991 Dec;231(4):482-97
1793176
Neuroscience. 2008 Jan 2;151(1):232-41
18065154
J R Soc Med. 1991 Aug;84(8):460-5
1886113
Brain Res Mol Brain Res. 1998 Mar 30;55(1):54-60
9645960
Neurosci Lett. 1999 Dec 10;276(3):157-60
10612629
J Nutr. 2000 Apr;130(4S Suppl):1043S-5S
10736378
Ann Neurol. 2002 May;51(5):641-4
12112114
Arch Dis Child. 1998 Jul;79(1):73-7
9771258
J Neurosci. 2005 Sep 28;25(39):8889-97
16192378
Neuroscience. 1999;93(4):1491-506
10501474
J Pharmacol Sci. 2006;100(5):433-42
16799259
Annu Rev Neurosci. 1992;15:353-75
1575447
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
4110397
Brain. 2005 Jun;128(Pt 6):1344-57
15758032
J Neurosci. 2001 Jan 1;21(1):356-62
11150353
J Biol Chem. 2007 Jun 22;282(25):18100-18107
17472959
Peptides. 1986 Jan-Feb;7(1):155-9
3520509
Ann Neurol. 2003 Mar;53(3):413-6
12601713
Pharmacol Rep. 2006 Jan-Feb;58(1):75-82
16531633
Behav Brain Res. 2009 Aug 12;201(2):292-9
19428647
Nature. 1986 Feb 27-Mar 5;319(6056):774-6
2869411